HuGE Literature Finder
Records 1-6
|
HER2 mutation status in Japanese HER2-negative breast cancer patients.
Japanese journal of clinical oncology 2014 Jul 44 (7): 619-23. Endo Yumi, Dong Yu, Yoshimoto Nobuyasu, Asano Tomoko, Hato Yukari, Yamashita Hiroko, Sato Shinya, Takahashi Satoru, Fujii Yoshitaka, Toyama Tatsu |
|
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Cancer research 2005 Jun 65 (12): 5076-83. Le Calvez Florence, Mukeria Anush, Hunt Jay D, Kelm Olaf, Hung Rayjean J, Tanière Philippe, Brennan Paul, Boffetta Paolo, Zaridze David G, Hainaut Pier |
|
Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study.
BMC gastroenterology 2005 5 (): 17. Willis Gavin, Bardsley Vicky, Fellows Ian W, Lonsdale Ray, Wimperis Jennie Z, Jennings Barbara |
|
Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma.
Cancer detection and prevention 2003 27 (2): 139-46. Casson A G, Zheng Z, Chiasson D, MacDonald K, Riddell D C, Guernsey J R, Guernsey D L, McLaughlin |
|
Outcome in prostate cancer associations with skin type and polymorphism in pigmentation-related genes.
Carcinogenesis 2001 Sep 22 (9): 1343-7. Luscombe C J, French M E, Liu S, Saxby M F, Jones P W, Fryer A A, Strange R |
|
Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 0 7 (3): 230-41. Lee Won Jin, Brennan Paul, Boffetta Paolo, London Stephanie J, Benhamou Simone, Rannug Agneta, To-Figueras Jordi, Ingelman-Sundberg Magnus, Shields Peter, Gaspari Laura, Taioli Emanue |
- Page last reviewed:Mar 16, 2019
- Page last updated:Apr 02, 2020
- Content source: